Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer
- 12 January 2016
- journal article
- research article
- Published by Elsevier BV in Urologic Oncology
- Vol. 34 (5), 235.e11-235.e16
- https://doi.org/10.1016/j.urolonc.2015.12.003
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Circulating tumor cells and DNA as liquid biopsiesGenome Medicine, 2013
- Detection of circulating tumor cells in different stages of prostate cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2013
- Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancerBritish Journal of Cancer, 2009
- Circulating Prostate Tumor Cells Detected by Reverse Transcription-PCR in Men with Localized or Castration-Refractory Prostate Cancer: Concordance with CellSearch Assay and Association with Bone Metastases and with SurvivalClinical Chemistry, 2009
- Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial dataThe Lancet Oncology, 2009
- Circulating Tumor Cells in Peripheral Blood Samples From Patients With Increased Serum Prostate Specific Antigen: Initial Results in Early Prostate CancerJournal of Urology, 2008
- External Validation of a Biomarker-Based Preoperative Nomogram Predicts Biochemical Recurrence After Radical ProstatectomyJournal of Clinical Oncology, 2008
- Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA‐elevation in serumInternational Journal of Cancer, 2005
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerThe New England Journal of Medicine, 2004
- ABILITY OF THE 1992 AND 1997 AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEMS FOR PROSTATE CANCER TO PREDICT PROGRESSION-FREE SURVIVAL AFTER RADICAL PROSTATECTOMY FOR STAGE T2 DISEASEJournal of Urology, 2000